144 related articles for article (PubMed ID: 3805107)
1. Heparin neutralising activity of whole blood in patients undergoing vascular surgery.
Harbourne T; Nicolaides AN; Golcman L; Shiffrin E
J Cardiovasc Surg (Torino); 1987; 28(1):22-5. PubMed ID: 3805107
[TBL] [Abstract][Full Text] [Related]
2. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
3. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
[TBL] [Abstract][Full Text] [Related]
4. Heparin activity monitoring during vascular surgery.
Jacobsen W; Brauer F; Smith LL
Am J Surg; 1978 Jul; 136(1):141-4. PubMed ID: 677381
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of two activated clotting time monitors during cardiac surgery.
Reich DL; Zahl K; Perucho MH; Thys DM
J Clin Monit; 1992 Jan; 8(1):33-6. PubMed ID: 1538250
[TBL] [Abstract][Full Text] [Related]
6. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
7. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
[TBL] [Abstract][Full Text] [Related]
8. [Activated thromboplastin time, plasma heparin and plasma fibrinogen using the Fibrintimer 10].
Khayat MC; Laforet F; Khayat A; Derlon A; Lequerrec A; Thomas M
Ann Biol Clin (Paris); 1988; 46(8):696-700. PubMed ID: 3218791
[TBL] [Abstract][Full Text] [Related]
9. In vivo heparin response and consumption in patients before and during arterial reconstructive surgery.
Stelmach WS; Myers KA; Scott DF; Devine TJ; Lee L
J Cardiovasc Surg (Torino); 1991; 32(2):166-73. PubMed ID: 2019617
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of heparin assay for coagulation management in newborns undergoing ECMO.
Khaja WA; Bilen O; Lukner RB; Edwards R; Teruya J
Am J Clin Pathol; 2010 Dec; 134(6):950-4. PubMed ID: 21088159
[TBL] [Abstract][Full Text] [Related]
11. [Heparin level and coagulation potential after subcutaneous injection of 7500 international units of heparin calcium].
Briel RC
Dtsch Med Wochenschr; 1984 Jun; 109(25):993-6. PubMed ID: 6734457
[TBL] [Abstract][Full Text] [Related]
12. Does the preparation of heparin influence anticoagulation during cardiopulmonary bypass?
Boldt J; Zickmann B; Ballesteros M; Scholz D; Dapper F; Hempelmann G
J Cardiothorac Vasc Anesth; 1991 Oct; 5(5):449-53. PubMed ID: 1932649
[TBL] [Abstract][Full Text] [Related]
13. Activated coagulation time in monitoring heparinized dogs.
Green RA
Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of intraoperative heparinization in vascular surgery.
Manny J; Romanoff H; Hyam E; Manny N
Surgery; 1976 Nov; 80(5):641-3. PubMed ID: 982283
[TBL] [Abstract][Full Text] [Related]
15. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
[TBL] [Abstract][Full Text] [Related]
16. Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration.
Koerber JM; Smythe MA; Begle RL; Mattson JC; Kershaw BP; Westley SJ
Pharmacotherapy; 1999 Aug; 19(8):922-31. PubMed ID: 10453963
[TBL] [Abstract][Full Text] [Related]
17. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
Hellebrekers LJ; Slappendel RJ; van den Brom WE
Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
[TBL] [Abstract][Full Text] [Related]
18. Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery.
Mabry CD; Thompson BW; Read RC
Am J Surg; 1979 Dec; 138(6):894-900. PubMed ID: 507308
[TBL] [Abstract][Full Text] [Related]
19. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
[TBL] [Abstract][Full Text] [Related]
20. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
